search
Back to results

Pulsed Radiofrequency for Emotional Stress (TcPRF)

Primary Purpose

Chronic Pain

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
TcPRF
Placebo
Sponsored by
Swiss Paraplegic Research, Nottwil
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Chronic Pain

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • age 18 - 65
  • chronic pain (Duration of three Months or more) patients of the Pain Center, Swiss Paraplegic Center, Nottwil

Exclusion Criteria:

  • severe medical issues, such as cancer or comparable diseases
  • severe mental disorders such as severe depression or schizophrenia
  • patients with pacemakers or with atrial fibrillation
  • Women who are pregnant or breast-feeding

Sites / Locations

  • Pain Center, Swiss Paraplegic Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

TcPRF Group

Placebo Group

Arm Description

According to the standard application of the device, for the PRF procedure one 5 x 13 cm skin electrode will be placed over the forehead, the other one over the posterior aspect of the neck. PRF with a duty load of 14.8 msec/sec and an average pulse frequency of 5.11 Hz will be applied for 25min. The voltage will be set to generate a current of 1 A. Voltage and impedance will be monitored continuously during treatment and if necessary the voltage will be corrected to ensure the proper current.

The setup will be made as for active treatment but no current will be delivered. The patients will not be able to feel any difference to the real treatment.

Outcomes

Primary Outcome Measures

Physiological status - Change between Baseline and Follow-up 1
physiological status, assessed by the heart rate variability (HRV)

Secondary Outcome Measures

Subjective Wellbeing - Change between Baseline and Follow-up 1 & 2
Secondary outcome is the subjective well-being, as assessed by the FW-7 questionnaire
Intensity of pain - Change between Baseline and Follow-up 1 & 2
the intensity of pain is assessed by the Numeric Rating Scale for pain (NRS) score by a 7-point Likert scale

Full Information

First Posted
November 18, 2016
Last Updated
August 2, 2018
Sponsor
Swiss Paraplegic Research, Nottwil
search

1. Study Identification

Unique Protocol Identification Number
NCT02972099
Brief Title
Pulsed Radiofrequency for Emotional Stress
Acronym
TcPRF
Official Title
The Psychological Effects of Transcutaneous Pulsed Radiofrequency (TcPRF) in Patients With Emotional Stress
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
November 2016 (Actual)
Primary Completion Date
December 2017 (Actual)
Study Completion Date
July 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Swiss Paraplegic Research, Nottwil

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The objective of the study is to assess the short-term and long-term effects of transcutaneous pulsed radio frequency treatment on the physiological status, subjective well-being, and on the intensity of pain. Category A Transcutaneous Pulsed Radiofrequency is a method that is widely used for control of pain. There are no known complications. In this study a Radiofrequency generator will be used that has a separate outlet for transcutaneous use. Patients will be recruited within the clinic population of patients.
Detailed Description
Data will be assessed in at three times, the baseline testing, the first and the second follow-up meeting (+2-4 days of intervention; as well as + 40 days via post/email) The inclusion criteria are: Inclusion: age 18 - 65 chronic pain (Duration of three Months or more) patients of the Pain Center Nottwil, Swiss Paraplegic Center The following criteria will lead to an exclusion of the study: severe medical issues, such as cancer or comparable diseases severe mental disorders such as severe depression or schizophrenia patients with pacemakers or with atrial fibrillation Women who are pregnant or breast-feeding The primary outcome assessed is the physiological status, assessed by the heart rate variability (HRV). Secondary outcomes are the subjective well-being, as assessed by the "Marburger questionnaire regarding habitual well-being" (FW-7) questionnaire as well as the intensity of pain, as assessed by the numeric rating scale for pain intensity (NRS) score and by a 7-point Likert scale.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Pain

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TcPRF Group
Arm Type
Experimental
Arm Description
According to the standard application of the device, for the PRF procedure one 5 x 13 cm skin electrode will be placed over the forehead, the other one over the posterior aspect of the neck. PRF with a duty load of 14.8 msec/sec and an average pulse frequency of 5.11 Hz will be applied for 25min. The voltage will be set to generate a current of 1 A. Voltage and impedance will be monitored continuously during treatment and if necessary the voltage will be corrected to ensure the proper current.
Arm Title
Placebo Group
Arm Type
Placebo Comparator
Arm Description
The setup will be made as for active treatment but no current will be delivered. The patients will not be able to feel any difference to the real treatment.
Intervention Type
Device
Intervention Name(s)
TcPRF
Other Intervention Name(s)
TOP Lesion Generator TLG-10 (TOP Corporation - Tokyo, Japan)
Intervention Description
Transcutaneous Pulsed Radiofrequency is a method that is widely used for control of pain. There are no known complications. In this study a Radiofrequency generator will be used that has a separate outlet for transcutaneous use. It is used in the daily clinical practice in the Pain Center of the Swiss Paraplegic Center.
Intervention Type
Device
Intervention Name(s)
Placebo
Other Intervention Name(s)
TOP Lesion Generator TLG-10 (TOP Corporation - Tokyo, Japan)
Intervention Description
In the Placebo Treatment, no current will be delivered. Since no sensations are produced by TcPRF treatment the patients won't recognize the difference.
Primary Outcome Measure Information:
Title
Physiological status - Change between Baseline and Follow-up 1
Description
physiological status, assessed by the heart rate variability (HRV)
Time Frame
Baseline; Follow-up 1 (+2-4 days)
Secondary Outcome Measure Information:
Title
Subjective Wellbeing - Change between Baseline and Follow-up 1 & 2
Description
Secondary outcome is the subjective well-being, as assessed by the FW-7 questionnaire
Time Frame
Baseline; Follow-up 1 (+2-4 days); Follow-up 2 (+40 days by post)
Title
Intensity of pain - Change between Baseline and Follow-up 1 & 2
Description
the intensity of pain is assessed by the Numeric Rating Scale for pain (NRS) score by a 7-point Likert scale
Time Frame
Baseline; Follow-up 1 (+2-4 days); Follow-up 2 (+40 days by post)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age 18 - 65 chronic pain (Duration of three Months or more) patients of the Pain Center, Swiss Paraplegic Center, Nottwil Exclusion Criteria: severe medical issues, such as cancer or comparable diseases severe mental disorders such as severe depression or schizophrenia patients with pacemakers or with atrial fibrillation Women who are pregnant or breast-feeding
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Lacher, Dr. phil.
Organizational Affiliation
Pain Center, Swiss Paraplegic Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pain Center, Swiss Paraplegic Center
City
Nottwil
State/Province
Luzern
ZIP/Postal Code
6207
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Pulsed Radiofrequency for Emotional Stress

We'll reach out to this number within 24 hrs